Combination of pan-RAF and MEK inhibitors in NRAS mutant melanoma.
Atefi M, Titz B, Avramis E, Ng C, Wong DJ, Lassen A, Cerniglia M, Escuin-Ordinas H, Foulad D, Comin-Anduix B, Graeber TG, Ribas A.
Atefi M, et al.
Mol Cancer. 2015 Feb 3;14(1):27. doi: 10.1186/s12943-015-0293-5.
Mol Cancer. 2015.
PMID: 25645078
Free PMC article.